Q87* (p.Gln87Ter) variant of ABL2 (Tyrosine-protein kinase ABL2)
Q87* (p.Gln87Ter) in ABL2 (Tyrosine-protein kinase ABL2) is a protein-truncating change. Clinical records from UniProt describe it as variant assessed as somatic; high impact.
Q87* (p.Gln87Ter) variant details
- p.Gln87Ter
- NCI-TCGA TCGA novel
- Variant assessed as somatic; high impact.
- Stop Gained
- UniProt: Variant assessed as somatic; high impact.